A.I. Pioneer Issues Urgent Warning to Americans

With artificial intelligence creeping into every facet of our lives, what should you be doing to "A.I.-Proof" your future? It's the question on many of our minds.

Click here to see Louis' new video for yourself.

Rady Johnson Biography and Net Worth

Insider of Pfizer

Rady Johnson is Executive Vice President and Pfizer’s Chief Compliance, Quality and Risk Officer. He has overall responsibility for the company's global compliance program, Regulatory Quality Assurance organization, global security efforts, and Office of the Ombuds.

Since joining Pfizer in 1994, Rady has led the Regulatory Law practice group as well as the Corporate Regulatory and Healthcare Law Audit functions, established the Legal Division’s Global Products Counsel practice group, and served as Senior Vice President and Associate General Counsel for the innovative segments of Pfizer’s Worldwide Biopharmaceuticals Business. Prior to joining the company, Rady was in private practice in Washington, DC, with the law firm of Hogan & Hartson, where he was a member of their food and drug law practice. Previously, Rady was a Certified Public Accountant specializing in the healthcare and hospitality industries for Arthur Anderson. He is a graduate of the University of Richmond and the Georgetown University Law Center.

Rady was recognized by the Ethisphere Institute in 2015 as an Attorney Who Matters for his work in helping to “pioneer a corporate and industry-wide legacy of ethics and integrity.” He chairs the International Federation of Pharmaceutical Manufacturers & Associations' Ethics & Business Integrity Committee, serves on the board of directors of the Pro Bono Partnership and the Citizens Crime Commission of New York City, is an adjunct professor at the University of Connecticut School of Law, and is very active in many local charities and organizations in his hometown of Westport, CT.

What is Rady A. Johnson's net worth?: The estimated net worth of Rady A. Johnson is at least $1.52 million as of March 15th, 2019. Mr. Johnson owns 59,797 shares of Pfizer stock worth more than $1,517,947 as of April 18th. This net worth evaluation does not reflect any other assets that Mr. Johnson may own. Learn More about Rady A. Johnson's net worth.
How old is Rady A. Johnson?: Mr. Johnson is currently 62 years old. There are 6 older executives and no younger executives at Pfizer. The oldest executive at Pfizer is Dr. Mikael Dolsten M.D., Ph.D., Chief Scientific Officer and President of Research & Development, who is 66 years old. Learn More on Rady A. Johnson's age.
How do I contact Rady A. Johnson?: The corporate mailing address for Mr. Johnson and other Pfizer executives is 235 EAST 42ND STREET, NEW YORK NY, 10017. Pfizer can also be reached via phone at (212) 733-2323. Learn More on Rady A. Johnson's contact information.
Has Rady A. Johnson been buying or selling shares of Pfizer?: Rady A. Johnson has not been actively trading shares of Pfizer in the last ninety days. Most recently, Rady A. Johnson sold 8,700 shares of the business's stock in a transaction on Friday, March 15th. The shares were sold at an average price of $41.13, for a transaction totalling $357,831.00. Following the completion of the sale, the insider now directly owns 59,797 shares of the company's stock, valued at $2,459,450.61. Learn More on Rady A. Johnson's trading history.
Who are Pfizer's active insiders?: Pfizer's insider roster includes Ronald Blaylock (Director), Albert Bourla (DVM), Loretta Cangialosi (VP), William Carapezzi, Jr. (EVP), Albert D.V.M. (DVM), Frank Damelio (EVP), Frank D'Amelio (CFO & Exec. VP ), Jennifer Damico (SVP), Jennifer Damico (SVP), Scott Gottlieb (Director), Rady Johnson (Insider), Douglas Lankler (EVP), Alexander Mackenzie (EVP), Laurie Olson (Insider), Ian Read (CEO), Dawn Rogers (EVP), Sally Susman (Insider), and John Young (Insider). Learn More on Pfizer's active insiders.
Are insiders buying or selling shares of Pfizer?: In the last year, Pfizer insiders bought shares 3 times. They purchased a total of 5,000 shares worth more than $156,410.00. The most recent insider tranaction occured on December, 15th when Director Scott Gottlieb bought 3,000 shares worth more than $79,410.00. Insiders at Pfizer own 0.1% of the company. Learn More about insider trades at Pfizer.
Information on this page was last updated on 12/15/2023.

Rady A. Johnson Insider Trading History at Pfizer

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/15/2019	Sell	8,700	$41.13	$357,831.00	59,797
3/13/2018	Sell	27,323	$36.55	$998,655.65	70,332
12/15/2017	Sell	8,000	$37.07	$296,560.00	46,963
3/10/2017	Sell	4,500	$34.19	$153,855.00	54,963

Rady A. Johnson Buying and Selling Activity at Pfizer

Pfizer Company Overview

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Today's Range

Now: $25.39

$25.23

$25.46

50 Day Range

MA: $27.14

$25.39

$28.37

2 Week Range

Now: $25.39

$25.23

$40.56

Volume

35,716,955 shs

Average Volume

42,482,289 shs

Market Capitalization

$143.74 billion

P/E Ratio

70.51

Dividend Yield

6.54%

Beta

0.61

A.I. Pioneer Issues Urgent Warning to Americans

From TradeSmith | Ad